You are here

ASC30

Ascletis begins dosing in Phase IIa trial of ASC30 for obesity treatment

Clinical Trials Arena

Thu, 07/3/25 - 11:26 am

Ascletis Pharma

clinical trials

Ascletis sees no benefit to high, fast oral GLP-1 dose titration, takes low, slow regimen forward

Fierce Biotech

Wed, 04/23/25 - 10:59 am

clinical trials

Ascletis' swift surge into obesity continues with competitive oral GLP-1 data

Fierce Biotech

Wed, 02/19/25 - 09:47 pm

Ascletis Pharma

clinical trials

Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial

Clinical Trials Arena

Tue, 01/21/25 - 11:27 am

Ascletis Pharma

clinical trials